AIM-PMR: A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154

Sponsor
AbbVie (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04972968
Collaborator
(none)
160
119
4
31
1.3
0

Study Details

Study Description

Brief Summary

Polymyalgia rheumatica (PMR) is an inflammatory disease causing shoulder, hip, and neck pain and stiffness, in adults aged 50 years or older. This study evaluates how safe and effective ABBV-154 is in participants with glucocorticoid-dependent PMR. Adverse events and change in disease activity will be assessed.

ABBV-154 is an investigational drug being evaluated for the treatment of PMR. Participants will be randomized into 1 of 4 treatment groups or arms, each arm receiving a different treatment. There is a 1 in 4 chance that a participant will be assigned to placebo. Around 160 participants, of at least 50 years of age, with PMR will be enrolled in the study at approximately 95 sites worldwide.

The study is compromised of a 52 week double-blind, placebo-controlled period and a follow-up visit 70 days after the last dose of the study drug. All participants will receive a glucocorticoid taper along with the assigned dose of ABBV-154 or placebo, subcutaneously (SC) every other week (eow).

There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Condition or Disease Intervention/Treatment Phase
Phase 2

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment
Actual Study Start Date :
Sep 9, 2021
Anticipated Primary Completion Date :
Jul 17, 2023
Anticipated Study Completion Date :
Apr 9, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: ABBV-154 Dose A

Participants in this group will receive dose A of ABBV-154 subcutaneously (SC) every other week (eow) for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.

Drug: ABBV-154
Subcutaneous Injection

Drug: Glucocorticoid
Oral Tablet

Experimental: ABBV-154 Dose B

Participants in this group will receive dose B of ABBV-154 SC eow for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.

Drug: ABBV-154
Subcutaneous Injection

Drug: Glucocorticoid
Oral Tablet

Experimental: ABBV-154 Dose C

Participants in this group will receive dose C of ABBV-154 SC eow for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.

Drug: ABBV-154
Subcutaneous Injection

Drug: Glucocorticoid
Oral Tablet

Placebo Comparator: Placebo

Participants will receive placebo SC eow for 52 weeks. In addition, participants will receive a glucocorticoid oral tablet taper.

Drug: Placebo
Subcutaneous Injection

Drug: Glucocorticoid
Oral Tablet

Outcome Measures

Primary Outcome Measures

  1. Time to Flare [Up to Week 52]

    Flare is defined as, presence of clinical signs and symptoms of PMR and requirement to increase the glucocorticoid dose per investigator.

Secondary Outcome Measures

  1. Percentage of Participants Achieving Flare-Free State [Up to Week 24]

    Percentage of participants achieving flare-free state.

  2. Cumulative Glucocorticoid Dose [Week 24]

    Cumulative glucocorticoid dose.

  3. Change from Baseline in Glucocorticoid Dose [Week 24]

    Change from Baseline in glucocorticoid dose.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical diagnosis of Polymyalgia Rheumatica (PMR) and fulfillment of the 2012 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) provisional classification criteria for PMR.

  • Must have had at least 2 episodes of unequivocal PMR flare.

  • Must be on a stable dose of prednisone.

  • Must be willing to follow the protocol-defined glucocorticoid tapering regimen.

Exclusion Criteria:
  • Have been treated with a prior TNF antagonist.

  • Current use of immunomodulators other than prednisone and hydroxychloroquine.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Arthritis and Rheumatism Associates /ID# 232089 Jonesboro Arkansas United States 72401-6251
2 Providence Medical Foundation /ID# 228681 Fullerton California United States 92835
3 Care Access Research, Huntington Beach /ID# 228677 Huntington Beach California United States 92648
4 San Diego Rheumatology /ID# 245391 La Mesa California United States 91942
5 Arthritis & Osteo Medical Ctr /ID# 228680 La Palma California United States 90623-1728
6 Hans Richard Barthel, M.D., Inc /ID# 231902 Santa Barbara California United States 93108
7 Medvin Clinical Research /ID# 228675 Tujunga California United States 91042-2706
8 Inland Rheum & Osteo Med Grp /ID# 228679 Upland California United States 91786
9 Denver Arthritis Clinic /ID# 245736 Denver Colorado United States 80230
10 Delaware Arthritis /ID# 230110 Lewes Delaware United States 19958
11 Arthritis & Rheumatic Disease Specialties /ID# 245448 Aventura Florida United States 33180
12 Rheumatology Associates of South Florida (RASF) - Clinical Research /ID# 232238 Boca Raton Florida United States 33486
13 International Medical Research - Daytona /ID# 228765 Daytona Beach Florida United States 32117
14 Omega Research Debary, LLC /ID# 245450 DeBary Florida United States 32713-2260
15 Lakes Research, LLC /ID# 228757 Miami Florida United States 33014
16 HMD Research LLC /ID# 228767 Orlando Florida United States 32819
17 Springfield Clinic /ID# 228840 Springfield Illinois United States 62702-3749
18 Four Rivers Clinical Research /ID# 228858 Paducah Kentucky United States 42001
19 Rheumatology Consultants - Clinical Research /ID# 232137 Tupelo Mississippi United States 38801-4949
20 Dartmouth-Hitchcock Medical Center /ID# 229557 Lebanon New Hampshire United States 03756
21 Ocean Rheumatology, PA /ID# 232539 Toms River New Jersey United States 08755
22 Hospital for Special Surgery /ID# 228577 New York New York United States 10021
23 St. Lawrence Health System /ID# 229702 Potsdam New York United States 13676
24 Univ Rochester Med Ctr /ID# 232554 Rochester New York United States 14642
25 Paramount Medical Research Con /ID# 228839 Middleburg Heights Ohio United States 44130
26 Clinical Research Source, Inc. /ID# 231903 Perrysburg Ohio United States 43551
27 Altoona Ctr Clinical Res /ID# 232493 Duncansville Pennsylvania United States 16635
28 Articularis Healthcare Group, Inc d/b/a Low Country Rheumatology /ID# 228860 Summerville South Carolina United States 29486-7887
29 West Tennessee Research Institute /ID# 228854 Jackson Tennessee United States 38305
30 Rheumatology Care Center PLLC /ID# 232306 Bellaire Texas United States 77401-2900
31 DM Clinical Research - Tomball /ID# 245512 Tomball Texas United States 77375
32 Emeritus Research Sydney /ID# 229166 Botany New South Wales Australia 2019
33 Royal Prince Alfred Hospital /ID# 244888 Camperdown New South Wales Australia 2050
34 BJC Health /ID# 244839 Paramatta New South Wales Australia 2150
35 Tasman Health Care /ID# 230829 Southport Queensland Australia 4215
36 The Queen Elizabeth Hospital /ID# 229049 Woodville South South Australia Australia 5011
37 Emeritus Research /ID# 229270 Camberwell Victoria Australia 3124
38 Austin Health /ID# 229164 Heidelberg Victoria Australia 3084
39 Fiona Stanley Hospital /ID# 229050 Murdoch Western Australia Australia 6150
40 Rheuma-Zentrum Wien-Oberlaa GmbH /ID# 229436 Vienna Wien Austria 1100
41 Rheumatology Research Associates /ID# 230363 Edmonton Alberta Canada T5M 0H4
42 The Waterside Clinic /ID# 230364 Barrie Ontario Canada L4M 6L2
43 CISSSBSL -Hopital regional de Rimouski /ID# 228394 Rimouski Quebec Canada G5L 5T1
44 Centre de Recherche Musculo-Squelettique /ID# 228392 Trois-rivières Quebec Canada G8Z 1Y2
45 CHU de Besancon - Jean Minjoz /ID# 244897 Besancon Doubs France 25030
46 CHU Montpellier - Hôpital Lapeyronie /ID# 228347 Montpellier Herault France 34090
47 Centre Hospitalier du Mans /ID# 229044 Le Mans CEDEX 9 Sarthe France 72037
48 Hopital de la Cavale Blanche /ID# 228348 Brest France 29200
49 CHRU Tours - Hopital Trousseau /ID# 228349 Chambray Les Tours France 37170
50 AP-HP - Hopital Cochin /ID# 231800 Paris France 75014
51 Medius Klinik Kirchheim /ID# 228660 Kirchheim unter Teck Baden-Wuerttemberg Germany 73230
52 Immanuel Krankenhaus Berlin /ID# 228659 Berlin-buch Germany 13125
53 Charite Universitaetsmedizin Berlin - Campus Mitte /ID# 228661 Berlin Germany 10117
54 MVZ Rheumatologie und Autoimmunmedizin Hamburg GmbH /ID# 228658 Hamburg Germany 20095
55 Rheumazentrum Ratingen /ID# 245183 Ratingen Germany 40882
56 Debreceni Egyetem Klinikai Kozpont /ID# 241674 Debrecen Hajdu-Bihar Hungary 4032
57 Obudai Egeszsegugyi Centrum Kft. /ID# 231121 Budapest Pest Hungary 1036
58 Clinexpert Kft /ID# 229677 Budapest Hungary 1033
59 Bekes Megyei Kozponti Korhaz Pandy Kalman Tagkorhaz /ID# 229758 Gyula Hungary 5700
60 Pest Megyei Flor Ferenc Korhaz /ID# 229676 Kistarcsa Hungary 2143
61 CMED Rehabilitacios es Diagnosztikai Kozpont /ID# 230065 Szekesfehervar Hungary 8000
62 Csongrad-Csanad Megyei Dr. Bugyi Istvan Korhaz /ID# 229793 Szentes Hungary 6600
63 Vital Medical Center Orvosi es Fogaszati Kozpont (Vital Medicina Kft.) /ID# 229674 Veszprém Hungary 8200
64 Obudai Egeszsegugyi Centrum Kft. Zalaegerszeg /ID# 229759 Zalaegerszeg Hungary 8900
65 ASL 3 Genovese - Ospedale la Colletta /ID# 229282 Arenzano Genova Italy 16011
66 Azienda Ospedaliero-Universitaria di Modena /ID# 228825 Modena Italy 41124
67 Fondazione IRCCS Policlinico /ID# 245274 Pavia Italy 27100
68 Azienda Ospedaliero-Universitaria Senese-Ospedale Santa Maria delle Scotte /ID# 245273 Siena Italy 53100
69 A.O.U. Citta della Salute e della Scienza di Torino /ID# 229080 Turin Italy 10126
70 Azienda Ospedaliera Universitaria Friuli Centrale/Presidio Ospedaliero Universit /ID# 228815 Udine Italy 33100
71 Daido Clinic /ID# 230204 Nagoya-shi Aichi Japan 457-8511
72 NHO Nagoya Medical Center /ID# 232420 Nagoya-shi Aichi Japan 460-0001
73 National Hospital Organization Shimoshizu National Hospital /ID# 230500 Yotsukaido-shi Chiba Japan 284-0003
74 Matsuyama Red Cross Hospital /ID# 230458 Matsuyama-shi Ehime Japan 790-8524
75 Sanuki Municipal Hospital /ID# 230202 Sanuki-shi Kagawa Japan 769-2393
76 Kuwana City Medical Center /ID# 231936 Kuwana-shi Mie Japan 511-0061
77 Kyushu University Beppu Hospital /ID# 232250 Beppu-shi Oita Japan 874-0838
78 Japanese Red Cross Okayama Hospital /ID# 230857 Okayama-shi Okayama Japan 700-8607
79 Rinku Hashimoto Rheumatology Orthopaedics /ID# 246532 Izumisano-shi Osaka Japan 598-0048
80 Osaka Medical and Pharmaceutical University Hospital /ID# 246530 Takatsuki-shi Osaka Japan 569-8686
81 Tokyo Medical And Dental University Hospital /ID# 232206 Bunkyo-ku Tokyo Japan 113-8519
82 Toyama Prefectural Central Hospital /ID# 230616 Toyama-shi Toyama Japan 930-8550
83 Hanyang University Seoul Hospital /ID# 228719 Seoul Seoul Teugbyeolsi Korea, Republic of 04763
84 Kyungpook National University Hospital /ID# 228716 Daegu Korea, Republic of 41944
85 ZiekenhuisGroep Twente /ID# 229071 Almelo Netherlands 7609 PP
86 Universitair Medisch Centrum Groningen /ID# 227727 Groningen Netherlands 9713 GZ
87 Medisch Centrum Leeuwarden /ID# 245442 Leeuwarden Netherlands 8934 AD
88 Maastricht Universitair Medisch Centrum /ID# 227779 Maastricht Netherlands 6229 HX
89 Maasstad Ziekenhuis /ID# 228064 Rotterdam Netherlands 3079 DZ
90 Optimal Clinical Trials Ltd /ID# 229048 Grafotn Auckland New Zealand 1010
91 Middlemore Clinical Trials /ID# 229099 Papatoetoe Auckland New Zealand 2025
92 Timaru Medical Specialists Ltd /ID# 229098 Timaru Canterbury New Zealand 7910
93 Waikato Hospital /ID# 229047 Hamilton Waikato New Zealand 3240
94 Wellington Regional Hospital /ID# 229490 Newtown Wellington New Zealand 6021
95 CGM Research Trust /ID# 244893 Christchurch Central New Zealand 8011
96 Niepubliczny Zaklad Opieki Zdrowotnej Biogenes Sp. z o.o /ID# 228357 Wroclaw Dolnoslaskie Poland 53-224
97 Szpital Uniwersytecki nr 2 im. dr. Jana Biziela /ID# 228353 Bydgoszcz Kujawsko-pomorskie Poland 85-168
98 Centrum Medyczne Reuma Park /ID# 244813 Warszawa Mazowieckie Poland 02-665
99 Nova Reuma Domyslawska I Rusilowicz - Spolka Partnerska Lekarza Reumatologa I Fi /Id# 228466 Bialystok Podlaskie Poland 15-707
100 AI Centrum Medyczne Sp. z o.o. sp.k. /ID# 228951 Poznan Wielkopolskie Poland 61-113
101 Ortopedyczno-Rehabilitacyjny Szpital Kliniczny im. Wiktora Degi /ID# 228314 Poznan Wielkopolskie Poland 61-545
102 Hospital Clínico Universitario de Santiago-CHUS /ID# 244868 Santiago de Compostela A Coruna Spain 15706
103 Consorci Corporacio Sanitaria Parc Tauli Sabadell /ID# 244866 Sabadell Barcelona Spain 08208
104 Hospital Unversitario Marques de Valdecilla /ID# 229297 Santander Cantabria Spain 39008
105 Hospital Universitario Canarias /ID# 229451 San Cristóbal de La Laguna Santa Cruz De Tenerife Spain 38320
106 Hospital Clinic de Barcelona /ID# 229295 Barcelona Spain 08036
107 Hospital General Universitario Gregorio Maranon /ID# 229302 Madrid Spain 28007
108 Hospital Clinico Universitario San Carlos /ID# 229296 Madrid Spain 28040
109 North West Anglia NHS Foundation Trust /ID# 230866 Bretton Cambridgeshire United Kingdom PE3 9GZ
110 Leicester Royal Infirmary /ID# 231967 Leicester England United Kingdom LE1 5WW
111 The Royal Free London NHS Foundation Trust /ID# 231707 London London, City Of United Kingdom NW3 2QG
112 Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 231966 Norwich Norfolk United Kingdom NR4 7UY
113 Cardiff & Vale University Health Board /ID# 245297 Cardiff Wales United Kingdom CF14 4XN
114 UH Coventry & Warwickshire /ID# 228588 Coventry United Kingdom CV2 2DX
115 NHS Lothian /ID# 245293 Edinburgh United Kingdom EH3 9HE
116 Liverpool University Hospitals NHS Foundation Trust /ID# 245296 Liverpool United Kingdom L7 8XP
117 Manchester University NHS Foundation Trust /ID# 230886 Manchester United Kingdom M13 9WL
118 Portsmouth Hospitals University NHS Trust /ID# 245291 Portsmouth United Kingdom PO6 3LY
119 The Royal Wolverhampton NHS Trust /ID# 230302 Wolverhampton United Kingdom WV10 0QP

Sponsors and Collaborators

  • AbbVie

Investigators

  • Study Director: ABBVIE INC., AbbVie

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
AbbVie
ClinicalTrials.gov Identifier:
NCT04972968
Other Study ID Numbers:
  • M20-370
  • 2021-000648-23
First Posted:
Jul 22, 2021
Last Update Posted:
Aug 12, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by AbbVie
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 12, 2022